Literature DB >> 10194451

A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.

D Wisniewski1, A Strife, S Swendeman, H Erdjument-Bromage, S Geromanos, W M Kavanaugh, P Tempst, B Clarkson.   

Abstract

Because of the probable causal relationship between constitutive p210(bcr/abl) protein tyrosine kinase activity and manifestations of chronic-phase chronic myelogenous leukemia (CML; myeloid expansion), a key goal is to identify relevant p210 substrates in primary chronic-phase CML hematopoietic progenitor cells. We describe here the purification and mass spectrometric identification of a 155-kD tyrosine phosphorylated protein associated with src homologous and collagen gene (SHC) from p210(bcr/abl)-expressing hematopoietic cells as SHIP2, a recently reported, unique SH2-domain-containing protein closely related to phosphatidylinositol polyphosphate 5-phosphatase SHIP. In addition to an N-terminal SH2 domain and a central catalytic region, SHIP2 (like SHIP1) possesses both potential PTB(NPXY) and SH3 domain (PXXP) binding motifs. Thus, two unique 5-ptases with striking structural homology are coexpressed in hematopoietic progenitor cells. Stimulation of human hematopoietic growth factor responsive cell lines with stem cell factor (SCF), interleukin-3 (IL-3), and granulocyte-macrophage colony-stimulating factor (GM-CSF) demonstrate the rapid tyrosine phosphorylation of SHIP2 and its resulting association with SHC. This finding suggests that SHIP2, like that reported for SHIP1 previously, is linked to downstream signaling events after activation of hematopoietic growth factor receptors. However, using antibodies specific to these two proteins, we demonstrate that, whereas SHIP1 and SHIP2 selectively hydrolyze PtdIns(3,4,5)P3 in vitro, only SHIP1 hydrolyzes soluble Ins(1,3,4,5)P4. Such an enzymatic difference raises the possibility that SHIP1 and SHIP2 may serve different functions. Preliminary binding studies using lysates from p210(bcr/abl)-expressing cells indicate that both Ptyr SHIP2 and Ptyr SHIP1 bind to the PTB domain of SHC but not to its SH2 domain. Interestingly, SHIP2 was found to selectively bind to the SH3 domain of ABL, whereas SHIP1 selectively binds to the SH3 domain of Src. Furthermore, in contrast to SHIP1, SHIP2 did not bind to either the N-terminal or C-terminal SH3 domains of GRB2. These observations suggest (1) that SHIP1 and SHIP2 may have a different hierarchy of binding SH3 containing proteins and therefore may modulate different signaling pathways and/or localize to different cellular compartments and (2) that they may be substrates for tyrosine phosphorylation by different tyrosine kinases. Because recent evidence has clearly implicated both PI(3,4, 5)P3 and PI(3,4)P2 in growth factor-mediated signaling, our finding that both SHIP1 and SHIP2 are constitutively tyrosine phosphorylated in CML primary hematopoietic progenitor cells may thus have important implications in p210(bcr/abl)-mediated myeloid expansion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194451

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  30 in total

1.  Distribution of the src-homology-2-domain-containing inositol 5-phosphatase SHIP-2 in both non-haemopoietic and haemopoietic cells and possible involvement of SHIP-2 in negative signalling of B-cells.

Authors:  E Muraille; X Pesesse; C Kuntz; C Erneux
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

2.  Proteome-wide detection of Abl1 SH3-binding peptides by integrating computational prediction and peptide microarray.

Authors:  Zheng Xu; Tingjun Hou; Nan Li; Yang Xu; Wei Wang
Journal:  Mol Cell Proteomics       Date:  2011-10-24       Impact factor: 5.911

3.  The inositol phosphatase SHIP-2 down-regulates FcgammaR-mediated phagocytosis in murine macrophages independently of SHIP-1.

Authors:  Jing Ai; Amita Maturu; Wesley Johnson; Yijie Wang; Clay B Marsh; Susheela Tridandapani
Journal:  Blood       Date:  2005-09-22       Impact factor: 22.113

4.  Charting the molecular network of the drug target Bcr-Abl.

Authors:  Marc Brehme; Oliver Hantschel; Jacques Colinge; Ines Kaupe; Melanie Planyavsky; Thomas Köcher; Karl Mechtler; Keiryn L Bennett; Giulio Superti-Furga
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-20       Impact factor: 11.205

5.  The inositol 5-phosphatase SHIP-1 and adaptors Dok-1 and 2 play central roles in CD4-mediated inhibitory signaling.

Authors:  Paul M Waterman; Susanne Marschner; Erin Brandl; John C Cambier
Journal:  Immunol Lett       Date:  2012-02-24       Impact factor: 3.685

6.  Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.

Authors:  T Wada; T Sasaoka; M Funaki; H Hori; S Murakami; M Ishiki; T Haruta; T Asano; W Ogawa; H Ishihara; M Kobayashi
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

Review 7.  PI3K signaling in cancer: beyond AKT.

Authors:  Evan C Lien; Christian C Dibble; Alex Toker
Journal:  Curr Opin Cell Biol       Date:  2017-03-24       Impact factor: 8.382

8.  SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels.

Authors:  Sylvie Giuriato; Xavier Pesesse; Stéphane Bodin; Takehiko Sasaki; Cécile Viala; Evelyne Marion; Joseph Penninger; Stéphane Schurmans; Christophe Erneux; Bernard Payrastre
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

9.  Mitochondrial gene expression and increased oxidative metabolism: role in increased lifespan of fat-specific insulin receptor knock-out mice.

Authors:  Masa Katic; Adam R Kennedy; Igor Leykin; Andrew Norris; Aileen McGettrick; Stephane Gesta; Steven J Russell; Matthias Bluher; Eleftheria Maratos-Flier; C Ronald Kahn
Journal:  Aging Cell       Date:  2007-12       Impact factor: 9.304

10.  A common phosphotyrosine signature for the Bcr-Abl kinase.

Authors:  Valerie L Goss; Kimberly A Lee; Albrecht Moritz; Julie Nardone; Erik J Spek; Joan MacNeill; John Rush; Michael J Comb; Roberto D Polakiewicz
Journal:  Blood       Date:  2006-02-23       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.